C.K. Cooper Reiterates QLT Buy, $12 PT

C.K. Cooper reiterated its QLT

Buy rating and $12 price target in a research report published today. In the report, C.K. Cooper states, "We believe that the company's assets coupled with the near and medium-term developmental pipeline (retinoid & punctual plugs) represent significant upside potential from current levels." Shares of QLT were trading at $6.95 at the time of posting, up 4.20% from Wednesday's market close.